Cantor Fitzgerald analyst Olivia Brayer Saunders reiterated an Overweight rating and $35.00 price target on Tenax Therapeutics (NASDAQ: TENX).The analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE